511509 — Vivo Bio Tech Income Statement
0.000.00%
Last trade - 00:00- IN₹511.27m
- IN₹1.17bn
- IN₹533.35m
Annual income statement for Vivo Bio Tech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 514 | 522 | 455 | 467 | 533 |
| Cost of Revenue | |||||
| Gross Profit | 400 | 455 | 416 | 409 | 452 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 430 | 400 | 337 | 352 | 431 |
| Operating Profit | 83.7 | 122 | 118 | 115 | 102 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 44.7 | 46.2 | 40.6 | 87.9 | 48.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 22 | 26.5 | 25.3 | 72.8 | -17.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 22 | 26.5 | 25.3 | 72.8 | -17.1 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 22 | 26.5 | 25.3 | 72.8 | -17.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.55 | 1.79 | 1.51 | 2.26 | -0.82 |